Conspicuous crystalline lens foreign body after intravitreal injection;Auffälliger Linsenfremdkörper nach intravitrealer Injektion

Ophthalmologe

Volumn 109, Issue 11, 2012, Pages 1119-1121

  Koller, S ^a   Neuhann, T ^a   Neuhann, I ^a  

^a Diagnostik München   (Germany)

Author keywords

Dexamethasone; Ozurdex; Posterior capsular defect; Retinal vein occlusion; Traumatic cataract

Indexed keywords

DEXAMETHASONE;

ARTICLE; BIODEGRADABLE IMPLANT; CASE REPORT; DRUG IMPLANT; FEMALE; FOREIGN BODY; HUMAN; INJURY; INTRAVITREAL DRUG ADMINISTRATION; LENS; MIDDLE AGED; PATHOLOGY; RETINA ARTERY OCCLUSION; RETINA MACULA EDEMA;

ABSORBABLE IMPLANTS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; FOREIGN BODIES; HUMANS; INTRAVITREAL INJECTIONS; LENS, CRYSTALLINE; MACULAR EDEMA; MIDDLE AGED; RETINAL ARTERY OCCLUSION;

EID: 84870377547     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-012-2650-8     Document Type: Article

References (6)

1. Cavalcante L, Cavalcante M, Murray T et al (2010) Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol 4:519-524
2. Fung A, Rosenfeld P, Reichel E (2006) The International Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90:1344-1349
3. Meyer CH, Michels S, Rodrigues EB et al (2011) Incidence of rhegmatogenous retinal detachements after intravitreal antivascular endothelial factor injections. Acta Ophthalmol 89:70-75
4. Meyer CH, Rodrigues EB, Michels S et al (2010) Incidence of damage to the crystalline lens during intravitreal injections. J Ocul Pharmacol Ther 26(5):491-495
5. Schmitz K, Meyer CH, Maier M et al (2011) Ozurdex in der klinischen Routine: Intraoperative und postoperative Komplikationen und Nebenwirkungen der intravitrealen Applikation von Dexamethason. Posterausstellung DOG, Abstract Nr. 742
6. Vajpayee R, Sharma N, Dada T et al (2001) Management of posterior capsule tears. Surv Ophthalmol 45:473-488